Womens Imaging

DBT yields promise for women with family history of breast cancer
By Amerigo Allegretto
DBT screening reduced recall rates and improved specificity over digital mammography in women with a family history of breast cancer.
May 22, 2025
Breast Dbt Social
Trans, gender-diverse patients more likely to be diagnosed with DCIS
By Amerigo Allegretto
Transgender and gender-diverse breast cancer patients are more likely to be diagnosed with DCIS and less likely to receive treatment.
May 22, 2025
Breast Cancer 3 D 400
RamSoft to integrate Therapixel's MammoScreen
By AuntMinnie.com staff writers
Commercial partnership adds AI-based breast cancer screening software to RamSoft's platforms.
May 21, 2025
Business Partner Handshake Intelligence
Abbreviated MRI suffices in imaging dense breasts
By Amerigo Allegretto
Abbreviated MRI produces images at a comparable quality to that of multiparametric MRI in imaging dense breasts.
May 20, 2025
Abbreviated axial MRI images show a 7-mm irregular mass with irregular margin (arrows) in the right upper inner quadrant with early rapid enhancement (BIRADS 4). The participant was recalled and underwent an MRI-guided vacuum-assisted biopsy that showed sclerosing adenosis with microcalcifications and usual ductal hyperplasia and focal apocrine metaplasia. On the full-protocol images (not shown), the lesion was T2-weighted hypointense and showed diffusion restriction and washout kinetics in the delayed phase, characteristics that would not have reversed the decision to recall the participant.
Lunit hits 1M mammogram milestone a year after Volpara purchase
By AuntMinnie.com staff writers
Lunit has achieved the milestone of helping to screen more than 1 million annual mammograms in North America.
May 19, 2025
Lunit
Pandemic tied to breast biopsy delays
By Amerigo Allegretto
Compared with the pre-COVID-19 period, women are more likely now to face delays in image-guided breast biopsy.
May 15, 2025
Breast Cancer2 400
Breast texture patterns on mammo may predict cancer risk in dense breasts
By Amerigo Allegretto
Radiomic phenotypes found on mammography may be linked to elevated breast cancer risk in women with dense breasts.
May 13, 2025
Full-field digital mammography (FFDM) images in a 52-year-old woman show a high-risk phenotype (top), and FFDM images in a 58-year-old woman show a low-risk phenotype (bottom). The high-risk phenotype was defined by having high values of the first principal component (PC1) and was assigned to cluster 3 (top row), and the low-risk phenotype was defined by having low values of the PC1 and was assigned to cluster 1 (bottom row). The index images (left side; before any diagnosis of cancer) are provided as well as follow-up images obtained at either the time of cancer diagnosis (for the high-risk phenotype, top right) or at the last follow-up (low-risk phenotype, bottom right). The red circle indicates the location of subsequent breast cancer. Both women had a BI-RADS breast density of C. The woman at high risk for breast cancer was Black and the woman at low risk for breast cancer was white.
Video from ISMRM: Katja Pinker lauds the many benefits of breast MRI
By Kate Madden Yee
In an interview with AuntMinnie, Katja Pinker, MD, PhD, offered an overview of current techniques and protocols for breast MRI.
May 11, 2025
Katja Interview
Komen rails against proposed federal cuts to women's health program
By Amerigo Allegretto
Susan G. Komen is warning of proposed federal budget cuts to a program that helps breast and cervical cancer patients get proper care.
May 9, 2025
Mammography Breast Ipad Patient 400
Cancer incidence on rise in younger people, women
By Amerigo Allegretto
Early-onset cancer incidence trends are rising among younger people, and women carry more of the burden.
May 8, 2025
Cancer Cell Target 400
About half of women undecided on AI's use in breast imaging
By Amerigo Allegretto
The jury is out on AI use in breast imaging, but women with a higher education and more health literacy are more likely to welcome it.
May 7, 2025
Breast Computer Monitor Mammogram
Ultrafast breast MRI's advantages may need to be reconsidered
By Amerigo Allegretto
Ultrafast MRI fell short of expectations when compared to DCE-MRI in terms of lesion conspicuity and classification.
May 6, 2025
Images depict axial MRI scans in a 50-year-old premenopausal female patient with biopsy-proven 12-mm invasive lobular cancer in the lower outer quadrant of the left breast. Upper images are subtracted dynamic contrast-enhanced (DCE) MRI scans from the first and second postcontrast acquisitions. Lower images are ultrafast MRI scans obtained within 24 hours after the DCE study (four consecutive subtracted dynamic frames from time points [T] 6–9). There is marked background parenchymal enhancement (BPE) on the DCE MRI scans. Thus, the known cancer (arrow) is barely visible; it exhibits only slightly stronger enhancement than the normal fibroglandular tissue, which results in low conspicuity. At ultrafast MRI there is less BPE, and still the cancer is barely visible because it starts to enhance simultaneously with the BPE. The conspicuity of the cancer is even reduced compared with the DCE series. Both of the readers missed this cancer on both the DCE and ultrafast MRI scans.
Page 1 of 686
Next Page